MEPRIMET P 2 TABLET

Product Description

MEPRIMET P 2 TABLET is a triple combination anti-diabetic formulation designed for optimal glycemic control in Type 2 Diabetes Mellitus. Each tablet combines Glimepiride 2mg, Metformin 500mg (Sustained Release), and Pioglitazone 15mg, offering a comprehensive approach to insulin resistance, glucose production, and pancreatic function.Ideal for pharma wholesalers, hospital pharmacies, retailers, and bulk medical buyers, this powerful oral anti-diabetic solution ensures better patient adherence, therapeutic efficacy, and market demand.Key Benefits: Targets multiple pathways of glucose regulation for enhanced diabetes management Once-daily dose supports better compliance and sustained blood sugar control GMP-certified manufacturing ensuring high quality and safety Ideal for bulk procurement, institutional supply, and pharma tenders Applications: First-line or adjunct treatment in Type 2 Diabetes Mellitus Effective in patients with insulin resistance and high HbA1c levels Widely prescribed in endocrinology and internal medicine practices Why Choose MEPRIMET P 2 TABLET? Clinically effective triple therapy in one tablet High-margin potential for medical distributors and retailers Available for bulk orders, third-party manufacturing, and custom labeling